Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Aitechpark18 Mar, 2021Technology
Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods, today announced it has signed a non-exclusive license agreement with Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for Zora?s patented ceramide-analysis technology.
Related Bookmarks
- Nexign & MegaFon Finish Project Facilitating Digital Transformation
- Kaye Launches LabWatch� IoT � A Cloud-Based Monitoring System
- Avast CISO Jaya Baloo to Interview Ethical Hackers at SXSW 2021
- BreakBot: The Google Calendar Add-On That Knows You Deserve A Break
- What is a Common Reason To Hire an SEO Service?
- Find Reliable HR Software for Sale in Quebec
- Buy Online Amazing Payroll Management Software in Canada
- Best Accounting Firm Management Software for Universities in Canada
- What Are Retrogen�s Covid-19 Test Benefits
- Hire Ipad Pro In Dubai Have Proved to Benefit Entrepreneurs
Recent Profiles
Cổng Game Hitclub
Kèo Nhà Cái
Zhongrun
Rohittendulkar
Paintedbookmug
Local News In Simi Valley
58win
Lamesa
Pathology Laboratory Near Me
Ihsan Noor